These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 18213476

  • 1. Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells.
    Molloy TJ, Bosma AJ, van't Veer LJ.
    Breast Cancer Res Treat; 2008 Nov; 112(2):297-307. PubMed ID: 18213476
    [Abstract] [Full Text] [Related]

  • 2. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.
    Cancer Lett; 2008 May 18; 263(2):267-79. PubMed ID: 18262345
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
    Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ, Tai YC.
    J Chromatogr A; 2007 Aug 31; 1162(2):154-61. PubMed ID: 17561026
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K, Sollier C, Jabado N.
    Expert Rev Proteomics; 2007 Dec 31; 4(6):741-56. PubMed ID: 18067413
    [Abstract] [Full Text] [Related]

  • 8. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    J Urol; 2008 Oct 31; 180(4):1342-7. PubMed ID: 18707699
    [Abstract] [Full Text] [Related]

  • 9. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer.
    Vona G, Estepa L, Béroud C, Damotte D, Capron F, Nalpas B, Mineur A, Franco D, Lacour B, Pol S, Bréchot C, Paterlini-Bréchot P.
    Hepatology; 2004 Mar 31; 39(3):792-7. PubMed ID: 14999698
    [Abstract] [Full Text] [Related]

  • 10. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H, Alix-Panabières C, Müller I, Letang N, Vendrell JP, Rebillard X, Pantel K.
    Clin Cancer Res; 2009 Feb 01; 15(3):1032-8. PubMed ID: 19188176
    [Abstract] [Full Text] [Related]

  • 11. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL, Kobayashi Y, Zhao Q, Zeng W, Sridharan S, Fan T, Adler HL, Yera ER, Zarrabi MH, Zucker S, Simko J, Chen WT, Rosenberg J.
    Cancer Lett; 2009 May 18; 277(2):164-73. PubMed ID: 19162393
    [Abstract] [Full Text] [Related]

  • 12. Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood.
    da Costa A, Oliveira JT, Gärtner F, Kohn B, Gruber AD, Klopfleisch R.
    Vet J; 2011 Oct 18; 190(1):165-8. PubMed ID: 21051248
    [Abstract] [Full Text] [Related]

  • 13. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C, Hu L, Xia L, Li Y.
    Clin Biochem; 2009 Feb 18; 42(3):194-200. PubMed ID: 19022237
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT.
    Clin Cancer Res; 2009 Feb 01; 15(3):1005-12. PubMed ID: 19188172
    [Abstract] [Full Text] [Related]

  • 15. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C, Hu L, Xia L, Li Y.
    Jpn J Clin Oncol; 2008 Nov 01; 38(11):770-6. PubMed ID: 18845519
    [Abstract] [Full Text] [Related]

  • 16. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.
    Breast Cancer Res Treat; 2009 Oct 01; 117(3):525-34. PubMed ID: 19016323
    [Abstract] [Full Text] [Related]

  • 17. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
    Bluemke K, Bilkenroth U, Meye A, Fuessel S, Lautenschlaeger C, Goebel S, Melchior A, Heynemann H, Fornara P, Taubert H.
    Cancer Epidemiol Biomarkers Prev; 2009 Aug 01; 18(8):2190-4. PubMed ID: 19661076
    [Abstract] [Full Text] [Related]

  • 18. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B, Sleijfer S, Foekens JA, Gratama JW.
    Cancer Treat Rev; 2009 Aug 01; 35(5):463-74. PubMed ID: 19410375
    [Abstract] [Full Text] [Related]

  • 19. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R.
    Lung Cancer; 2009 Apr 01; 64(1):92-7. PubMed ID: 18804892
    [Abstract] [Full Text] [Related]

  • 20. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
    Liu L, Liao GQ, He P, Zhu H, Liu PH, Qu YM, Song XM, Xu QW, Gao Q, Zhang Y, Chen WF, Yin YH.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):756-60. PubMed ID: 18514066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.